EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab

Chemotherapy alone has limited ability to significantly improve survival in non-small lung cancer (NSCLC) beyond what has already been achieved. The epidermal growth factor (EGF) pathway plays a vital role in the pathogenesis and progression of NSCLC. Two classes of drugs inhibit the EGF receptor (E...

Descripción completa

Detalles Bibliográficos
Autores principales: Reade, Chad A, Ganti, Apar Kishor
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726075/
https://www.ncbi.nlm.nih.gov/pubmed/19707410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726075/
https://www.ncbi.nlm.nih.gov/pubmed/19707410

Ejemplares similares